• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

semaglutide

Ozempic (semaglutide).
Posted inMetabolism, Research

Ozempic: Before and After. Dozens of Inspiring Weight Loss Success Stories

by Julia Mardi and Tanya von Reuss May 3, 2024May 3, 2024

What can you expect from Ozempic, a miracle drug for weight loss and more? Will your physical appearance change a lot? Will you feel more confident?

brain
Posted inClinical Trials, Neuroscience

Treating Parkinson’s disease with diabetes and obesity drugs

by Tanya von Reuss April 5, 2024April 24, 2024

GLP1R agonists like lixisenatide, exenatide, or semaglutide limit the progression of motor dysfunction in Parkinson’s disease.

heart
Posted inCardiology, Pharma & Biotech

Cardior Pharmaceuticals: Advanced Treatment for Heart Failure

by Mark Gubar and Timur Burkhanayev April 5, 2024April 5, 2024

RNA therapy reverses pathological cardiac remodeling, improving heart function and prolonging life.

insulin
Posted inAutoimmune Diseases, Metabolism, New Drugs, Regulatory

Awiqli: Basal Insulin Once a Week

by Tanya von Reuss and Mark Gubar March 14, 2024April 5, 2024

Novo Nordisk invented insulin icodec, a very patient-friendly ultra-long-acting insulin.

weight-loss-pills
Posted inClinical Trials, In the Pipeline, Metabolism

Most Effective Weight Loss Drugs: Present and Future

by Julia Mardi and Timur Burkhanayev July 3, 2022September 20, 2022

Modern pharmacological ways to combat obesity.

obesity
Posted inClinical Trials, Metabolism

Tirzepatide: Strong Weight-Loss Drug

by Tanya von Reuss June 6, 2022September 8, 2022

Losing 24 kilograms in a year and a half.

Posted inMetabolism, New Drugs, Regulatory

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus

by Mark Gubar, Tanya von Reuss and Timur Burkhanayev May 17, 2022September 8, 2022

Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.

Posts pagination

1 2 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×